Darunavir Ethanolate

乙醇达芦那韦

Report date: 2025/07/11 17:20:59
NME

Base Information

Drug NameDarunavir Ethanolate
Drug Alias Name地瑞那韦Darunavirum地瑞那韦乙醇盐达如那韦达芦那韦 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryUnited States
Original Approved Date2006/06/23
Country/TerritoryBelgiumCanadaPanama +[34] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTibotec
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson Innovative MedicineJanssen-Cilag International NvTibotec +[4] 
Inactive CompaniesUniversity Of Cape TownTibotec Pharmaceuticals, IrelandNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ05AE10
Related LinksWikipediaDrugBankKEGG